Skip to main content
SpringerLink
Log in

Cautious approach warranted for ERT in breast cancer survivors

  • Drug Reactions and Interactions
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Eden JA. Estrogen replacement therapy in survivors of breast cancer. A risk-benefit assessment. Drugs Aging 1996; 8(2): 127–33

    Article  PubMed  CAS  Google Scholar 

  2. Jacobs S, Hillard TC. Hormone replacement therapy in the aged. A state of the art review. Drugs Aging 1996; 8(3): 193–213

    Article  PubMed  CAS  Google Scholar 

  3. Colditz GA, Egan KM, Stampfer MJ. Hormone replacement therapy and risk of breast cancer: results from epidemiological studies. Am J Obstet Gynecol 1993; 168: 1473–80

    PubMed  CAS  Google Scholar 

  4. Sillero-Arenas M, Delgado-Rodriquez M, Rodriquez-Cantera R, et al. Menopausal hormone replacement therapy and breast cancer: a meta-analysis. Obstet Gynecol 1992; 79: 286–94

    PubMed  CAS  Google Scholar 

  5. Dupont WD, Page DL. Menopausal oestrogen replacement therapy and breast cancer. Arch Intern Med 1991; 151: 67–72

    Article  PubMed  CAS  Google Scholar 

  6. Steinberg KK, Thanker SB, Smith SJ, et al. A meta-analysis of the effects of oestrogen replacement therapy and the risk of breast cancer. JAMA 1991; 265: 1985–90

    Article  PubMed  CAS  Google Scholar 

  7. Grady D, Rubin SM, Petitti SB, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992; 117: 1016–37

    PubMed  CAS  Google Scholar 

  8. Colditz JA, Hankinson SE, Hunter DJ, et al. The use of oestrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 1995; 332(24): 1589–93

    Article  PubMed  CAS  Google Scholar 

  9. Rose C, Mouridsen HT. Endocrine management and advanced breast cancer. Horm Res 1989; 32 Suppl. 1: 189–97

    Article  PubMed  Google Scholar 

  10. Eden JA, Bush T, Nand S, et al. A case controlled study of combined continuous oestrogen-progestin replacement therapy among women with a personal history of breast cancer. Menopause 1995; 2(2): 67–72

    Article  Google Scholar 

  11. Sands R, Boshoff C, Jones A, et al. Current opinion: hormone replacement therapy after a diagnosis of breast cancer. Menopause 1995; 2(2): 73–80

    Article  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cautious approach warranted for ERT in breast cancer survivors. Drugs Ther. Perspect 8, 11–13 (1996). https://doi.org/10.2165/00042310-199608030-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199608030-00004

Search

Navigation